Introduction
Flavonoids are a class of phenolic compounds widely distributed in plants. Over one thousand individual types are known, and the list is constantly expanding. It has been found that components of this kind have many medical functions, such as diuretic, laxative, antispasmodic, antihypertensive and anti-inflammatory actions. 1 
Artemisia annua L. (Asteraceae) is an annual herb endemic to the northern parts of
Chahar and Suiyuan provinces in China where it is known as 'quinghao' and it has been used to treat chills and fever for more than 2000 years. 2, 3 It had been reported that some flavones from A. annua potentiated the antimicrobial activity of artemisinin against Plasmodium falciparum and other malarial causing parasites. 4, 5 It has been proposed that this activity is due to its inhibition of the multidrug resistant (MDR) pumps in Plasmodium falciparum and in Staphylococcus aureus. 6 Flavonols which bear a free hydroxyl group at C-3 were ineffective as inhibitors of the S. aureus MDR pump. 4 Chrysosplenol B (1), also known as chrysosplenetin, and chrysosplenol D (2) are isolated from A. annua [3] [4] [5] [6] and showed potentiated artemisinin activity against Plasmodium falciparum. Both flavonols bear methoxy groups at C-3 as shown in Figure 1 . 3 Chrysosplenol B (1) and chrysosplenol D (2) are also isolated from Chrysosplenium plants [7] [8] [9] , a medicinal herb for the treatment of the common cold, which is considered to be mainly due to rhinovirus infection. Tsuchiya and coworkers reported that 3-methoxyl and 5-hydroxyl groups on the flavone skeleton conferred potent specific antiviral activity against rhinovirus. 7 Both chrysosplenol B (1) and chrysosplenol D (2) bear 3-methoxyl and 5-hydroxyl groups.
The 3-methoxylated flavones are rare in nature. Therefore, total synthesis of chrysosplenol B (1) and chrysosplenol D (2) has been studied. 6, 10, 11 Fukui and coworkers started the synthesis of chrysosplenol B with conversion of iretol (3) to 2, 4, 6-trihydroxy-3, ω-dimethoxyacetophenone (4) by a Hoesch condensation with methoxyacetonitrile. The ketone was subjected to the Allan-Robinson flavone synthesis using o-benzylvanillic anhydride (5) to give 4'-benzyloxy-5, 7-dihydroxy-3, 3', 6-trimethoxyflavone (6). The partial methylation of hydorxyflavone (6) with diazomethane gave 4'-benzyloxy-5-hydroxy-3, 3', 6, 7-tetramethoxyflavone (7), which was then debenzylated to give 4', 5-dihydroxy-3, 3', 6, 7-tetramethoxyflavone, chrysosplenol B (1). 10 Chrysosplenol D (2) Chrysosplenol B (1) Figure 1 About a year later, Fukui and Nakayama synthesized chrysosplenol D (2) in similar manner. By using the method of Allan-Robinson's flavone synthesis, the reaction of the ketone 4 with 3, 4-dibenzyloxybenzoic anhydride (8) and potassium 3, 4-dibenzyloxybenzoate, followed by treatment with alcoholic potassium hydroxide gave a mixture of flavones. The mixture was acetylated without further purification to yield 5, 7-diacetoxy-3', 4'-dibenzyloxy-3, 6-dimethoxyflavone (9). Treatment of flavone 9 with dilute alkali gave 3', 4'-dibenzyloxy-5, 7-dihydroxy-3, 6-dimethoxyflavone (10). The partial methylation of flavone 10 gave 3', 4'-dibenzyloxy-5-hydroxy-3, 6, 7-trimethoxyflavone (11).
The debenzylation of flavone 11 yielded chrysosplenol D (2). This synthesis gave chrysosplenol D (2); however, it only gave 26% yield of flavone 9 from ketone 4. When we tried to reproduce this procedure, the AFO reaction did not proceed very well. This reaction gave mostly starting material. Therefore, we report herein an alternate synthesis of chrysosplenol D (2). The synthesis of chrysosplenol B (1) was carried out by a modification of this route.
Results and discussion
Our synthesis of chrysosplenol D (2) involved the synthesis of a chalcone intermediate from aldol condensation of ketone 12 with aldehyde 13 which would be subjected to oxidation to a flavone then to flavonol, methylation, and deprotection. 14 Ketone 12 and aldehyde 13 had similar R f values. To avoid purification problems, excess ketone was used to complete the consumption of the aldehyde.
In the Kraus and Roy synthesis of chrysosplenol D (2), they obtained a flavonol as the product in the AFO oxidation. to trans-2,3-dihydroflavonol (26) as shown in Scheme 10. 15 We have synthesized DMDO (23) using simplified procedure employed by Murray and Singh as shown in Scheme 9. 16 With our hydroxychalcone 14, we cyclized the chalcone using DMDO (23) 15 and then formed flavonol 16 by iodine oxidation 6 as shown in Scheme 11. However, the reaction gave low yield (< 5 %) due to low concentration of DMDO (23). This reaction gave mostly starting material. 
Dimethyldioxirane (23)
We tried oxidizing the chalcone 14 to flavone 19. 17 The reaction with iodine gave a low yield (< 10 %) and intractable mixture of compounds. All 1 H NMR spectra were recorded at 300 MHz or 400 MHz unless otherwise noted.
Unless otherwise noted, reactions were carried out under an argon atmosphere. Thin-layer chromatography was performed using commercially prepared 60-mesh silica gel plates (Whatman K6F), and visualization was effected using short wavelength UV light (254 nm).
All reagents were used directly as obtained commercially unless otherwise noted.
3, 4, 5-Trimethoxyphenyl acetate (21).
To 
1-(6-Hydroxy-2, 3, 4-trimethoxyphenyl)ethanone (12).
To a stirred solution of acetate 21 (3.0 g, 13 mmol) in glacial acetic acid (3 mL) at room temperature was added dropwise boron trifluoride-diethyl ether (6.0 mL, 47 mmol).
The mixture was heated for 2 hours at 70 °C. It was cooled and then poured into 10 % aqueous NaOH (125 mL). The mixture was washed with ether, the aqueous layer was cooled, acidified with concentrated HCl, then extracted with dichloromethane. 
4-Benzyloxy-3-methoxybenzaldehyde (33).
To a stirred solution of 4-hydroxy-3-methoxybenzaldehyde (12) (2.0 g, 13mmol) in acetone (40 mL) at room temperature was added benzyl bromide (2.3 mL, 20 mmol), and potassium carbonate (4.5 g, 33 mmol). The mixture was boiled for 4 hours. After completion of the reaction, the solid material was filtered off, and the solvent was evaporated. however, the pyruvate kinase enzyme is irreversible. Therefore, the enzymes pyruvate carboxylase and phosphoenolpyruvate carboxykinase are used to provide an alternate path for effectively reversing its actions.
Transcription of the PEPCK gene is stimulated by glucagon, glucocorticoids, retinoic acid, and adenosine 3', 5'-monophosphate (cAMP), while it is inhibited by insulin. Insulin inhibits the transcription of many of the stimulatory elements and, therefore, considered dominant of these factors. PEPCK activity is also inhibited by hydrazine sulfate, and the inhibition decreases the rate of gluconeogenesis. Also, the use of siRNA to inhibit PEPCK in a diabetic mouse model shows elimination of the hyperglycemia upon PEPCK inhibition.
Therefore, it would be advantageous to find novel inhibitors of PEPCK and/or an inhibitor scaffold for preparing analogs and derivatives for novel inhibitors of PEPCK.
1,2
In efforts to characterize the active sites of the isozymes of PEPCK, studies have been performed using analogs of PEP or OAA, either as reversible inhibitors or as alternative substrates. Derivatives of PEP with alkyl or halo substitutions have been used to demonstrate the stereospecificity of the reaction catalyzed by mitochondrial PEPCK (mPEPCK) from avian liver. [6] [7] [8] [9] Studies have shown that α-hydroxyl and α-sulfhydryl carboxylic acids are poor substrates for that enzyme's phosphoryl transfer reaction.
1, 2, 6
The molecular structure configuration for interacting with a binding site of PEPCK Knowing some characteristics of the inhibitors, development of novel inhibitors of the enzyme has been studied. One of the most important criteria in choosing compounds for the inhibitors was that they possess functional groups similar to those of the substrates.
Therefore, we focused on synthesizing compounds which were bicarboxylate and bicarboxylate with sulfonyl group, 3-(carboxymethylthio)-picolinic acid (1) and its analog, 
Results and discussion
When the synthesis of 3-(carboxymethylthio)-picolinic acid (1) was started, there was only one direct synthesis reported for this compound. NMR spectra of crude product showed more pure product than recrystallized product.
Therefore this compound was sent to Dr. Holyoak without purification to test for its activity.
Since we had some experience with dimethyldioxirane (DMDO), we have used DMDO to oxidize 3-(carboxymethylthio)-picolinic acid (1) to synthesize 3-(carboxymethylsulfonyl)-picolinic acid (2). We have had problems with the concentration of DMDO, therefore we used excess DMDO to react with 3-(carboxymethylthio)-picolinic acid (1) as shown in Scheme 4 15 . This reaction was carried smoothly with yield of 32 %.
In conclusion, we have successfully synthesized 3-(carboxymethylthio)-picolinic acid 
Experimental section
General.
All 1 H NMR spectra were recorded at 300 MHz or 400 MHz unless otherwise noted.
3-(Carboxymethylthio)-picolinic acid (1).
To hot concentrated hydrochloric acid (2.2 mL), β-aminopicolinic acid (5) (1.5 g, 10.6 mmol) was dissolved and then quickly cooled. Separated crystals were added in concentrated sodium nitrite solution (0.8 g). Clear, brownish liquid is poured into 0 °C of thioglycolic acid (6) (1.0 g, 10.9 mmol) in water (~2 mL). After 2 hours of stirring 1. 
GENERAL CONCLUSION
In the first chapter, we investigated the synthesis of chrysosplenol B, chrysosplenol D, and their analogs. We have modified the Kraus and Roy synthesis of chrysosplenol D. From
Kraus and Roy synthesis, we were unable to obtain flavonols using Algar-Flynn-Olyamada reaction. However, this research has led to an alternative method of forming flavonols from chalcones. We have oxidized chalcones to flavones using selenium dioxide and further oxidized flavones to flavonols using lithium diisopropylamide, trimethylborate and hydrogen peroxide. With our modified method, we were able to synthesized chrysosplenol D in six In the second chapter, we have synthesized 3-(carboxymethylthio)-picolinic acid and its analog, 3-(carboxymethylsulfonyl)-picolinic acid. Both of these compounds are bicarboxylates, 3-(carboxymethylsulfonyl)-picolinic acid with sulfonyl group which meets criteria in choosing compounds that they possess functional groups similar to those of the substrates, oxaloacetate, and phosphoenolpyruvate. These compounds can help researchers to study the mechanisms of molecular recognition of phosphoenolpyruvate and oxaloacetate by cytosolic phosphoenolpyruvate carboxykinase.
